![J. Alan Crunkleton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
J. Alan Crunkleton
Direttore operativo presso MateraCor, Inc.
Posizioni attive di J. Alan Crunkleton
Società | Posizione | Inizio | Fine |
---|---|---|---|
MateraCor, Inc.
![]() MateraCor, Inc. Medical SpecialtiesHealth Technology Part of BioVentrix, Inc., MateraCor, Inc. is a southern-based biotech start-up that develops novel approaches to prevent progression and reverse heart failure. The company is based in Aliso Viejo, CA. The company's lead product, Trans-Catheter Myocardial Restoration (TCMR), is an investigational device that consists of an implantable hydrogel and a minimally invasive endocardial delivery system to treat ischemic or non-ischemic heart failure with reduced ejection faction (HFREF). The CEO of the company is Frank A. Ahmann. MateraCor was acquired by BioVentrix, Inc. on January 27, 2022. | Direttore operativo | - | - |
Storia della carriera di J. Alan Crunkleton
Precedenti posizioni note di J. Alan Crunkleton
Società | Posizione | Inizio | Fine |
---|---|---|---|
Correx, Inc.
![]() Correx, Inc. Medical SpecialtiesHealth Technology Correx, Inc. manufactures surgical devices for aortic valve bypass (AVB) surgeries. The company was founded by Joseph L. Smith Jr., Richard M. Beane, James S. Gammie, and John W. Brown in 2004 and is headquartered in Waltham, MA. | Direttore/Membro del Consiglio | 23/02/2011 | 01/03/2014 |
Amministratore Delegato | 23/02/2011 | 01/03/2014 | |
Presidente | 23/02/2011 | 01/03/2014 | |
Northridge Tri-Modality Imaging, Inc.
![]() Northridge Tri-Modality Imaging, Inc. Medical SpecialtiesHealth Technology Northridge Tri-Modality Imaging, Inc. develops and manufactures multi-modality imaging systems used in pre-clinical research. It offers tri-modality imaging, PET imaging, SPECT imaging, CT imaging, and optical imaging. The company was founded in 2001 and is headquartered in Chatsworth, CA. | Amministratore Delegato | - | - |
Presidente | - | - |
Formazione di J. Alan Crunkleton
Massachusetts Institute of Technology | Doctorate Degree |
University of Massachusetts | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Posizioni
Chief Executive Officer | 2 |
President | 2 |
Doctorate Degree | 2 |
Settori
Health Technology | 4 |
Finance | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Correx, Inc.
![]() Correx, Inc. Medical SpecialtiesHealth Technology Correx, Inc. manufactures surgical devices for aortic valve bypass (AVB) surgeries. The company was founded by Joseph L. Smith Jr., Richard M. Beane, James S. Gammie, and John W. Brown in 2004 and is headquartered in Waltham, MA. | Health Technology |
Northridge Tri-Modality Imaging, Inc.
![]() Northridge Tri-Modality Imaging, Inc. Medical SpecialtiesHealth Technology Northridge Tri-Modality Imaging, Inc. develops and manufactures multi-modality imaging systems used in pre-clinical research. It offers tri-modality imaging, PET imaging, SPECT imaging, CT imaging, and optical imaging. The company was founded in 2001 and is headquartered in Chatsworth, CA. | Health Technology |
MateraCor, Inc.
![]() MateraCor, Inc. Medical SpecialtiesHealth Technology Part of BioVentrix, Inc., MateraCor, Inc. is a southern-based biotech start-up that develops novel approaches to prevent progression and reverse heart failure. The company is based in Aliso Viejo, CA. The company's lead product, Trans-Catheter Myocardial Restoration (TCMR), is an investigational device that consists of an implantable hydrogel and a minimally invasive endocardial delivery system to treat ischemic or non-ischemic heart failure with reduced ejection faction (HFREF). The CEO of the company is Frank A. Ahmann. MateraCor was acquired by BioVentrix, Inc. on January 27, 2022. | Health Technology |
- Borsa valori
- Insiders
- J. Alan Crunkleton
- Esperienza